Lu Zhiquan, Ye Zilu, Li Ping, Jiang Yike, Han Sanyang, Ma Lan
Precision Medicine and Healthcare Research Center, Tsinghua-Berkeley Shenzhen Institute (TBSI), Tsinghua Shenzhen International Graduate School, Tsinghua University, University Town of Shenzhen, Nanshan District, Shenzhen 518055, China.
Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, University Town of Shenzhen, Nanshan District, Shenzhen 518055, China.
Biosensors (Basel). 2024 Dec 12;14(12):608. doi: 10.3390/bios14120608.
Nasopharyngeal carcinoma (NPC) is a malignant tumor with high prevalence in southern China. Aberrant DNA methylation, as a hallmark of cancer, is extensively present in NPC, the detection of which facilitates early diagnosis and prognostic improvement of NPC. Conventional methylation detection methods relying on bisulfite conversion have limitations such as time-consuming, complex processes and sample degradation; thus, a more rapid and efficient method is needed.
We propose a novel DNA methylation assay based on methylation-sensitive restriction endonuclease (MSRE) HhaI digestion and Glycerol-enhanced recombinase polymerase amplification (RPA)-CRISPR/Cas12a detection (HGRC). MSRE has a fast digestion rate, and HhaI specifically cleaves unmethylated DNA at a specific locus, leaving the methylated target intact to trigger the downstream RPA-Cas12a detection step, generating a fluorescence signal. Moreover, the detection step was supplemented with glycerol for the separation of Cas12a-containing components and RPA- and template-containing components, which avoids over-consumption of the template and, thus, enhances the amplification efficiency and detection sensitivity.
The HGRC method exhibits excellent performance in the detection of a CNE2-specific methylation locus with a (limit of detection) LOD of 100 aM and a linear range of 100 aM to 100 fM. It also responds well to different methylation levels and is capable of distinguishing methylation levels as low as 0.1%. Moreover, this method can distinguish NPC cells from normal cells by detecting methylation in cellular genomes. This method provides a rapid and sensitive approach for NPC detection and also holds good application prospects for other cancers and diseases featuring DNA methylation as a biomarker.
鼻咽癌(NPC)是中国南方高发的恶性肿瘤。异常DNA甲基化作为癌症的一个标志,在鼻咽癌中广泛存在,其检测有助于鼻咽癌的早期诊断和预后改善。传统的依赖亚硫酸氢盐转化的甲基化检测方法存在耗时、过程复杂和样本降解等局限性;因此,需要一种更快速、高效的方法。
我们提出了一种基于甲基化敏感限制性内切酶(MSRE)HhaI消化和甘油增强重组酶聚合酶扩增(RPA)-CRISPR/Cas12a检测(HGRC)的新型DNA甲基化检测方法。MSRE具有快速消化率,HhaI在特定位点特异性切割未甲基化的DNA,使甲基化靶点保持完整以触发下游RPA-Cas12a检测步骤,产生荧光信号。此外,检测步骤中添加了甘油,用于分离含Cas12a的成分与含RPA和模板的成分,这避免了模板的过度消耗,从而提高了扩增效率和检测灵敏度。
HGRC方法在检测CNE2特异性甲基化位点时表现优异,检测限(LOD)为100 aM,线性范围为100 aM至100 fM。它对不同的甲基化水平也有良好反应,能够区分低至0.1%的甲基化水平。此外,该方法可以通过检测细胞基因组中的甲基化来区分NPC细胞和正常细胞。该方法为鼻咽癌检测提供了一种快速、灵敏的方法,对于以DNA甲基化为生物标志物特征的其他癌症和疾病也具有良好的应用前景。